nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—breast cancer	0.2	0.561	CbGaD
Riluzole—CYP1A1—breast cancer	0.156	0.439	CbGaD
Riluzole—CYP1A1—Toremifene—breast cancer	0.071	0.196	CbGbCtD
Riluzole—CYP1A2—Anastrozole—breast cancer	0.0347	0.0956	CbGbCtD
Riluzole—CYP1A2—Toremifene—breast cancer	0.0317	0.0874	CbGbCtD
Riluzole—ABCG2—Tamoxifen—breast cancer	0.0281	0.0774	CbGbCtD
Riluzole—ABCG2—Mitoxantrone—breast cancer	0.0274	0.0755	CbGbCtD
Riluzole—CYP1A1—Tamoxifen—breast cancer	0.0259	0.0715	CbGbCtD
Riluzole—ABCG2—Paclitaxel—breast cancer	0.0219	0.0603	CbGbCtD
Riluzole—ABCG2—Irinotecan—breast cancer	0.0216	0.0595	CbGbCtD
Riluzole—ABCG2—Fluorouracil—breast cancer	0.0207	0.0571	CbGbCtD
Riluzole—ABCG2—Carboplatin—breast cancer	0.0206	0.0567	CbGbCtD
Riluzole—ABCG2—Docetaxel—breast cancer	0.0158	0.0436	CbGbCtD
Riluzole—ABCG2—Doxorubicin—breast cancer	0.0118	0.0325	CbGbCtD
Riluzole—CYP1A2—Tamoxifen—breast cancer	0.0116	0.0319	CbGbCtD
Riluzole—ABCG2—Methotrexate—breast cancer	0.0114	0.0315	CbGbCtD
Riluzole—CYP1A2—Fluorouracil—breast cancer	0.00854	0.0235	CbGbCtD
Riluzole—SLC7A11—Betamethasone—Fluoxymesterone—breast cancer	0.000974	0.5	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Fluoxymesterone—breast cancer	0.000974	0.5	CbGdCrCtD
Riluzole—SLC7A11—adipose tissue—breast cancer	0.000147	0.103	CbGeAlD
Riluzole—SLC7A11—female reproductive system—breast cancer	0.000135	0.095	CbGeAlD
Riluzole—SLC7A11—female gonad—breast cancer	0.000123	0.0864	CbGeAlD
Riluzole—SLC7A11—endocrine gland—breast cancer	0.000114	0.0804	CbGeAlD
Riluzole—CYP1A2—nipple—breast cancer	8.55e-05	0.0602	CbGeAlD
Riluzole—CYP1A1—nipple—breast cancer	8.43e-05	0.0594	CbGeAlD
Riluzole—CYP1A1—epithelium—breast cancer	5.68e-05	0.04	CbGeAlD
Riluzole—CYP1A1—skin of body—breast cancer	5.4e-05	0.038	CbGeAlD
Riluzole—ABCG2—endometrium—breast cancer	5.36e-05	0.0378	CbGeAlD
Riluzole—ABCG2—uterus—breast cancer	4.94e-05	0.0348	CbGeAlD
Riluzole—ABCG2—pituitary gland—breast cancer	4.85e-05	0.0342	CbGeAlD
Riluzole—ABCG2—adipose tissue—breast cancer	4.83e-05	0.034	CbGeAlD
Riluzole—CYP1A1—uterus—breast cancer	4.69e-05	0.033	CbGeAlD
Riluzole—CYP1A1—adipose tissue—breast cancer	4.59e-05	0.0323	CbGeAlD
Riluzole—ABCG2—adrenal gland—breast cancer	4.34e-05	0.0305	CbGeAlD
Riluzole—CYP1A1—female reproductive system—breast cancer	4.22e-05	0.0297	CbGeAlD
Riluzole—ABCG2—bone marrow—breast cancer	4.19e-05	0.0295	CbGeAlD
Riluzole—ABCG2—female gonad—breast cancer	4.04e-05	0.0285	CbGeAlD
Riluzole—CYP1A1—female gonad—breast cancer	3.84e-05	0.027	CbGeAlD
Riluzole—CYP1A2—endocrine gland—breast cancer	3.62e-05	0.0255	CbGeAlD
Riluzole—CYP1A1—endocrine gland—breast cancer	3.57e-05	0.0251	CbGeAlD
Riluzole—ABCG2—lymph node—breast cancer	2.6e-05	0.0183	CbGeAlD
Riluzole—CYP1A1—lymph node—breast cancer	2.47e-05	0.0174	CbGeAlD
Riluzole—Urinary tract disorder—Doxorubicin—breast cancer	1.9e-05	9.6e-05	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—breast cancer	1.9e-05	9.57e-05	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—breast cancer	1.9e-05	9.57e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Docetaxel—breast cancer	1.89e-05	9.55e-05	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—breast cancer	1.89e-05	9.55e-05	CcSEcCtD
Riluzole—Dyspnoea—Capecitabine—breast cancer	1.89e-05	9.55e-05	CcSEcCtD
Riluzole—Fatigue—Docetaxel—breast cancer	1.89e-05	9.54e-05	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—breast cancer	1.89e-05	9.53e-05	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—breast cancer	1.89e-05	9.52e-05	CcSEcCtD
Riluzole—Nausea—Irinotecan—breast cancer	1.88e-05	9.5e-05	CcSEcCtD
Riluzole—Nausea—Mitoxantrone—breast cancer	1.88e-05	9.5e-05	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—breast cancer	1.88e-05	9.49e-05	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—breast cancer	1.88e-05	9.46e-05	CcSEcCtD
Riluzole—Constipation—Docetaxel—breast cancer	1.87e-05	9.46e-05	CcSEcCtD
Riluzole—Pain—Docetaxel—breast cancer	1.87e-05	9.46e-05	CcSEcCtD
Riluzole—Back pain—Methotrexate—breast cancer	1.87e-05	9.45e-05	CcSEcCtD
Riluzole—Dyspepsia—Capecitabine—breast cancer	1.87e-05	9.43e-05	CcSEcCtD
Riluzole—Chills—Epirubicin—breast cancer	1.87e-05	9.42e-05	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—breast cancer	1.86e-05	9.38e-05	CcSEcCtD
Riluzole—Asthenia—Paclitaxel—breast cancer	1.86e-05	9.36e-05	CcSEcCtD
Riluzole—Decreased appetite—Capecitabine—breast cancer	1.84e-05	9.31e-05	CcSEcCtD
Riluzole—Alopecia—Epirubicin—breast cancer	1.84e-05	9.28e-05	CcSEcCtD
Riluzole—Nausea—Gemcitabine—breast cancer	1.83e-05	9.26e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Capecitabine—breast cancer	1.83e-05	9.25e-05	CcSEcCtD
Riluzole—Fatigue—Capecitabine—breast cancer	1.83e-05	9.23e-05	CcSEcCtD
Riluzole—Pruritus—Paclitaxel—breast cancer	1.83e-05	9.23e-05	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—breast cancer	1.82e-05	9.2e-05	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—breast cancer	1.82e-05	9.19e-05	CcSEcCtD
Riluzole—Constipation—Capecitabine—breast cancer	1.81e-05	9.16e-05	CcSEcCtD
Riluzole—Pain—Capecitabine—breast cancer	1.81e-05	9.16e-05	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—breast cancer	1.81e-05	9.14e-05	CcSEcCtD
Riluzole—Feeling abnormal—Docetaxel—breast cancer	1.81e-05	9.12e-05	CcSEcCtD
Riluzole—Nausea—Fluorouracil—breast cancer	1.8e-05	9.1e-05	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—breast cancer	1.8e-05	9.08e-05	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—breast cancer	1.8e-05	9.06e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Docetaxel—breast cancer	1.79e-05	9.05e-05	CcSEcCtD
Riluzole—Anaemia—Methotrexate—breast cancer	1.79e-05	9.03e-05	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—breast cancer	1.79e-05	9.02e-05	CcSEcCtD
Riluzole—Flatulence—Epirubicin—breast cancer	1.78e-05	9.01e-05	CcSEcCtD
Riluzole—Tension—Epirubicin—breast cancer	1.78e-05	8.97e-05	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—breast cancer	1.77e-05	8.95e-05	CcSEcCtD
Riluzole—Diarrhoea—Paclitaxel—breast cancer	1.77e-05	8.93e-05	CcSEcCtD
Riluzole—Nervousness—Epirubicin—breast cancer	1.76e-05	8.88e-05	CcSEcCtD
Riluzole—Back pain—Epirubicin—breast cancer	1.75e-05	8.84e-05	CcSEcCtD
Riluzole—Feeling abnormal—Capecitabine—breast cancer	1.75e-05	8.83e-05	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—breast cancer	1.75e-05	8.82e-05	CcSEcCtD
Riluzole—Malaise—Methotrexate—breast cancer	1.75e-05	8.81e-05	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—breast cancer	1.74e-05	8.79e-05	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—breast cancer	1.74e-05	8.78e-05	CcSEcCtD
Riluzole—Vertigo—Methotrexate—breast cancer	1.74e-05	8.78e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Capecitabine—breast cancer	1.74e-05	8.76e-05	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—breast cancer	1.74e-05	8.76e-05	CcSEcCtD
Riluzole—Abdominal pain—Docetaxel—breast cancer	1.73e-05	8.74e-05	CcSEcCtD
Riluzole—Body temperature increased—Docetaxel—breast cancer	1.73e-05	8.74e-05	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—breast cancer	1.73e-05	8.74e-05	CcSEcCtD
Riluzole—Chills—Doxorubicin—breast cancer	1.73e-05	8.72e-05	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—breast cancer	1.72e-05	8.68e-05	CcSEcCtD
Riluzole—Dizziness—Paclitaxel—breast cancer	1.71e-05	8.63e-05	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—breast cancer	1.7e-05	8.59e-05	CcSEcCtD
Riluzole—Cough—Methotrexate—breast cancer	1.69e-05	8.52e-05	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—breast cancer	1.69e-05	8.51e-05	CcSEcCtD
Riluzole—Urticaria—Capecitabine—breast cancer	1.69e-05	8.51e-05	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—breast cancer	1.68e-05	8.48e-05	CcSEcCtD
Riluzole—Abdominal pain—Capecitabine—breast cancer	1.68e-05	8.47e-05	CcSEcCtD
Riluzole—Body temperature increased—Capecitabine—breast cancer	1.68e-05	8.47e-05	CcSEcCtD
Riluzole—Convulsion—Methotrexate—breast cancer	1.68e-05	8.46e-05	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—breast cancer	1.68e-05	8.46e-05	CcSEcCtD
Riluzole—Anaemia—Epirubicin—breast cancer	1.67e-05	8.45e-05	CcSEcCtD
Riluzole—Agitation—Epirubicin—breast cancer	1.66e-05	8.4e-05	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—breast cancer	1.65e-05	8.34e-05	CcSEcCtD
Riluzole—Myalgia—Methotrexate—breast cancer	1.65e-05	8.32e-05	CcSEcCtD
Riluzole—Chest pain—Methotrexate—breast cancer	1.65e-05	8.32e-05	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—breast cancer	1.65e-05	8.32e-05	CcSEcCtD
Riluzole—Tension—Doxorubicin—breast cancer	1.64e-05	8.3e-05	CcSEcCtD
Riluzole—Vomiting—Paclitaxel—breast cancer	1.64e-05	8.3e-05	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—breast cancer	1.64e-05	8.28e-05	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.64e-05	8.26e-05	CcSEcCtD
Riluzole—Malaise—Epirubicin—breast cancer	1.63e-05	8.24e-05	CcSEcCtD
Riluzole—Rash—Paclitaxel—breast cancer	1.63e-05	8.23e-05	CcSEcCtD
Riluzole—Dermatitis—Paclitaxel—breast cancer	1.63e-05	8.22e-05	CcSEcCtD
Riluzole—Discomfort—Methotrexate—breast cancer	1.63e-05	8.22e-05	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—breast cancer	1.63e-05	8.22e-05	CcSEcCtD
Riluzole—Vertigo—Epirubicin—breast cancer	1.63e-05	8.21e-05	CcSEcCtD
Riluzole—Syncope—Epirubicin—breast cancer	1.62e-05	8.2e-05	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—breast cancer	1.62e-05	8.18e-05	CcSEcCtD
Riluzole—Back pain—Doxorubicin—breast cancer	1.62e-05	8.18e-05	CcSEcCtD
Riluzole—Headache—Paclitaxel—breast cancer	1.62e-05	8.18e-05	CcSEcCtD
Riluzole—Hypersensitivity—Docetaxel—breast cancer	1.61e-05	8.15e-05	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—breast cancer	1.61e-05	8.13e-05	CcSEcCtD
Riluzole—Palpitations—Epirubicin—breast cancer	1.6e-05	8.08e-05	CcSEcCtD
Riluzole—Confusional state—Methotrexate—breast cancer	1.59e-05	8.04e-05	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—breast cancer	1.59e-05	8.03e-05	CcSEcCtD
Riluzole—Cough—Epirubicin—breast cancer	1.58e-05	7.98e-05	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—breast cancer	1.58e-05	7.97e-05	CcSEcCtD
Riluzole—Asthenia—Docetaxel—breast cancer	1.57e-05	7.94e-05	CcSEcCtD
Riluzole—Convulsion—Epirubicin—breast cancer	1.57e-05	7.92e-05	CcSEcCtD
Riluzole—Infection—Methotrexate—breast cancer	1.57e-05	7.92e-05	CcSEcCtD
Riluzole—Hypertension—Epirubicin—breast cancer	1.56e-05	7.89e-05	CcSEcCtD
Riluzole—Hypersensitivity—Capecitabine—breast cancer	1.56e-05	7.89e-05	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—breast cancer	1.56e-05	7.85e-05	CcSEcCtD
Riluzole—Pruritus—Docetaxel—breast cancer	1.55e-05	7.83e-05	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—breast cancer	1.55e-05	7.82e-05	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—breast cancer	1.55e-05	7.82e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—breast cancer	1.55e-05	7.81e-05	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—breast cancer	1.54e-05	7.78e-05	CcSEcCtD
Riluzole—Chest pain—Epirubicin—breast cancer	1.54e-05	7.78e-05	CcSEcCtD
Riluzole—Myalgia—Epirubicin—breast cancer	1.54e-05	7.78e-05	CcSEcCtD
Riluzole—Agitation—Doxorubicin—breast cancer	1.54e-05	7.77e-05	CcSEcCtD
Riluzole—Anxiety—Epirubicin—breast cancer	1.54e-05	7.76e-05	CcSEcCtD
Riluzole—Nausea—Paclitaxel—breast cancer	1.54e-05	7.75e-05	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—breast cancer	1.53e-05	7.74e-05	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.53e-05	7.73e-05	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—breast cancer	1.53e-05	7.71e-05	CcSEcCtD
Riluzole—Discomfort—Epirubicin—breast cancer	1.52e-05	7.69e-05	CcSEcCtD
Riluzole—Asthenia—Capecitabine—breast cancer	1.52e-05	7.68e-05	CcSEcCtD
Riluzole—Malaise—Doxorubicin—breast cancer	1.51e-05	7.63e-05	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—breast cancer	1.51e-05	7.61e-05	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—breast cancer	1.51e-05	7.6e-05	CcSEcCtD
Riluzole—Anorexia—Methotrexate—breast cancer	1.51e-05	7.6e-05	CcSEcCtD
Riluzole—Syncope—Doxorubicin—breast cancer	1.5e-05	7.59e-05	CcSEcCtD
Riluzole—Pruritus—Capecitabine—breast cancer	1.5e-05	7.58e-05	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—breast cancer	1.5e-05	7.57e-05	CcSEcCtD
Riluzole—Diarrhoea—Docetaxel—breast cancer	1.5e-05	7.57e-05	CcSEcCtD
Riluzole—Confusional state—Epirubicin—breast cancer	1.49e-05	7.52e-05	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—breast cancer	1.48e-05	7.47e-05	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—breast cancer	1.48e-05	7.46e-05	CcSEcCtD
Riluzole—Oedema—Epirubicin—breast cancer	1.48e-05	7.46e-05	CcSEcCtD
Riluzole—Hypotension—Methotrexate—breast cancer	1.48e-05	7.45e-05	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—breast cancer	1.47e-05	7.43e-05	CcSEcCtD
Riluzole—Infection—Epirubicin—breast cancer	1.47e-05	7.41e-05	CcSEcCtD
Riluzole—Cough—Doxorubicin—breast cancer	1.46e-05	7.38e-05	CcSEcCtD
Riluzole—Shock—Epirubicin—breast cancer	1.45e-05	7.34e-05	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—breast cancer	1.45e-05	7.33e-05	CcSEcCtD
Riluzole—Diarrhoea—Capecitabine—breast cancer	1.45e-05	7.33e-05	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—breast cancer	1.45e-05	7.32e-05	CcSEcCtD
Riluzole—Dizziness—Docetaxel—breast cancer	1.45e-05	7.31e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—breast cancer	1.45e-05	7.3e-05	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—breast cancer	1.45e-05	7.3e-05	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—breast cancer	1.44e-05	7.28e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.44e-05	7.26e-05	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—breast cancer	1.44e-05	7.25e-05	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—breast cancer	1.43e-05	7.21e-05	CcSEcCtD
Riluzole—Insomnia—Methotrexate—breast cancer	1.43e-05	7.21e-05	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—breast cancer	1.43e-05	7.2e-05	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—breast cancer	1.43e-05	7.2e-05	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—breast cancer	1.43e-05	7.2e-05	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—breast cancer	1.42e-05	7.18e-05	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—breast cancer	1.42e-05	7.16e-05	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.42e-05	7.15e-05	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—breast cancer	1.41e-05	7.11e-05	CcSEcCtD
Riluzole—Anorexia—Epirubicin—breast cancer	1.41e-05	7.11e-05	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—breast cancer	1.41e-05	7.11e-05	CcSEcCtD
Riluzole—Somnolence—Methotrexate—breast cancer	1.4e-05	7.09e-05	CcSEcCtD
Riluzole—Dizziness—Capecitabine—breast cancer	1.4e-05	7.08e-05	CcSEcCtD
Riluzole—Dry mouth—Doxorubicin—breast cancer	1.4e-05	7.04e-05	CcSEcCtD
Riluzole—Vomiting—Docetaxel—breast cancer	1.39e-05	7.03e-05	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—breast cancer	1.39e-05	7.02e-05	CcSEcCtD
Riluzole—Rash—Docetaxel—breast cancer	1.38e-05	6.97e-05	CcSEcCtD
Riluzole—Hypotension—Epirubicin—breast cancer	1.38e-05	6.97e-05	CcSEcCtD
Riluzole—Dermatitis—Docetaxel—breast cancer	1.38e-05	6.97e-05	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—breast cancer	1.38e-05	6.96e-05	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—breast cancer	1.37e-05	6.93e-05	CcSEcCtD
Riluzole—Headache—Docetaxel—breast cancer	1.37e-05	6.93e-05	CcSEcCtD
Riluzole—Oedema—Doxorubicin—breast cancer	1.37e-05	6.9e-05	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—breast cancer	1.37e-05	6.9e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—breast cancer	1.36e-05	6.88e-05	CcSEcCtD
Riluzole—Fatigue—Methotrexate—breast cancer	1.36e-05	6.87e-05	CcSEcCtD
Riluzole—Infection—Doxorubicin—breast cancer	1.36e-05	6.86e-05	CcSEcCtD
Riluzole—Pain—Methotrexate—breast cancer	1.35e-05	6.82e-05	CcSEcCtD
Riluzole—Vomiting—Capecitabine—breast cancer	1.35e-05	6.81e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.35e-05	6.8e-05	CcSEcCtD
Riluzole—Shock—Doxorubicin—breast cancer	1.35e-05	6.79e-05	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—breast cancer	1.34e-05	6.77e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—breast cancer	1.34e-05	6.76e-05	CcSEcCtD
Riluzole—Rash—Capecitabine—breast cancer	1.34e-05	6.75e-05	CcSEcCtD
Riluzole—Insomnia—Epirubicin—breast cancer	1.34e-05	6.75e-05	CcSEcCtD
Riluzole—Dermatitis—Capecitabine—breast cancer	1.34e-05	6.75e-05	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—breast cancer	1.34e-05	6.74e-05	CcSEcCtD
Riluzole—Headache—Capecitabine—breast cancer	1.33e-05	6.71e-05	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—breast cancer	1.33e-05	6.71e-05	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—breast cancer	1.33e-05	6.7e-05	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—breast cancer	1.32e-05	6.67e-05	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—breast cancer	1.32e-05	6.65e-05	CcSEcCtD
Riluzole—Somnolence—Epirubicin—breast cancer	1.31e-05	6.63e-05	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—breast cancer	1.3e-05	6.58e-05	CcSEcCtD
Riluzole—Nausea—Docetaxel—breast cancer	1.3e-05	6.57e-05	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—breast cancer	1.3e-05	6.57e-05	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—breast cancer	1.3e-05	6.57e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—breast cancer	1.29e-05	6.52e-05	CcSEcCtD
Riluzole—Decreased appetite—Epirubicin—breast cancer	1.29e-05	6.49e-05	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—breast cancer	1.28e-05	6.45e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—breast cancer	1.28e-05	6.44e-05	CcSEcCtD
Riluzole—Fatigue—Epirubicin—breast cancer	1.27e-05	6.43e-05	CcSEcCtD
Riluzole—Pain—Epirubicin—breast cancer	1.26e-05	6.38e-05	CcSEcCtD
Riluzole—Constipation—Epirubicin—breast cancer	1.26e-05	6.38e-05	CcSEcCtD
Riluzole—Nausea—Capecitabine—breast cancer	1.26e-05	6.36e-05	CcSEcCtD
Riluzole—Urticaria—Methotrexate—breast cancer	1.25e-05	6.33e-05	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—breast cancer	1.25e-05	6.3e-05	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—breast cancer	1.25e-05	6.3e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.25e-05	6.29e-05	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—breast cancer	1.24e-05	6.24e-05	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—breast cancer	1.23e-05	6.2e-05	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—breast cancer	1.22e-05	6.15e-05	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—breast cancer	1.22e-05	6.15e-05	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—breast cancer	1.22e-05	6.14e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—breast cancer	1.21e-05	6.1e-05	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—breast cancer	1.2e-05	6.08e-05	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—breast cancer	1.19e-05	6e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—breast cancer	1.18e-05	5.96e-05	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—breast cancer	1.18e-05	5.95e-05	CcSEcCtD
Riluzole—Urticaria—Epirubicin—breast cancer	1.17e-05	5.93e-05	CcSEcCtD
Riluzole—Pain—Doxorubicin—breast cancer	1.17e-05	5.9e-05	CcSEcCtD
Riluzole—Constipation—Doxorubicin—breast cancer	1.17e-05	5.9e-05	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—breast cancer	1.17e-05	5.9e-05	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—breast cancer	1.17e-05	5.9e-05	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—breast cancer	1.16e-05	5.87e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ALDOA—breast cancer	1.16e-05	0.000145	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NME1—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FHL2—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PHGDH—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADSL—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—UMPS—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK3—breast cancer	1.15e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.14e-05	0.000143	CbGpPWpGaD
Riluzole—Asthenia—Methotrexate—breast cancer	1.13e-05	5.72e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—BRIP1—breast cancer	1.13e-05	0.000141	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HPSE—breast cancer	1.13e-05	0.000141	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LDHB—breast cancer	1.13e-05	0.000141	CbGpPWpGaD
Riluzole—Feeling abnormal—Doxorubicin—breast cancer	1.13e-05	5.69e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—NCOA3—breast cancer	1.13e-05	0.000141	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Doxorubicin—breast cancer	1.12e-05	5.65e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—SLC2A2—breast cancer	1.12e-05	0.00014	CbGpPWpGaD
Riluzole—Pruritus—Methotrexate—breast cancer	1.12e-05	5.64e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—CHST9—breast cancer	1.12e-05	0.00014	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TGFB1—breast cancer	1.11e-05	0.000139	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CPT1A—breast cancer	1.1e-05	0.000137	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTR—breast cancer	1.1e-05	0.000137	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.09e-05	0.000137	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—breast cancer	1.09e-05	0.000137	CbGpPWpGaD
Riluzole—Hypersensitivity—Epirubicin—breast cancer	1.09e-05	5.5e-05	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—breast cancer	1.09e-05	5.48e-05	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—breast cancer	1.08e-05	5.46e-05	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—breast cancer	1.08e-05	5.46e-05	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—breast cancer	1.08e-05	5.45e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—HPGDS—breast cancer	1.07e-05	0.000135	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMMR—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA3—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCC1—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HBA1—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.06e-05	0.000133	CbGpPWpGaD
Riluzole—Asthenia—Epirubicin—breast cancer	1.06e-05	5.35e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—COX11—breast cancer	1.06e-05	0.000133	CbGpPWpGaD
Riluzole—Pruritus—Epirubicin—breast cancer	1.05e-05	5.28e-05	CcSEcCtD
Riluzole—Dizziness—Methotrexate—breast cancer	1.04e-05	5.27e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—GSTT1—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ACHE—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARGC1B—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—breast cancer	1.03e-05	0.000129	CbGpPWpGaD
Riluzole—Diarrhoea—Epirubicin—breast cancer	1.01e-05	5.1e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.01e-05	0.000126	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.01e-05	0.000126	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.01e-05	0.000126	CbGpPWpGaD
Riluzole—Hypersensitivity—Doxorubicin—breast cancer	1.01e-05	5.09e-05	CcSEcCtD
Riluzole—Vomiting—Methotrexate—breast cancer	1e-05	5.07e-05	CcSEcCtD
Riluzole—Rash—Methotrexate—breast cancer	9.96e-06	5.03e-05	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—breast cancer	9.95e-06	5.02e-05	CcSEcCtD
Riluzole—Headache—Methotrexate—breast cancer	9.9e-06	4.99e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—CYP17A1—breast cancer	9.87e-06	0.000124	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—breast cancer	9.81e-06	4.95e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CA9—breast cancer	9.79e-06	0.000123	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA4—breast cancer	9.79e-06	0.000123	CbGpPWpGaD
Riluzole—Dizziness—Epirubicin—breast cancer	9.78e-06	4.93e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ENO1—breast cancer	9.77e-06	0.000122	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS1—breast cancer	9.77e-06	0.000122	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SHMT1—breast cancer	9.68e-06	0.000121	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CDA—breast cancer	9.68e-06	0.000121	CbGpPWpGaD
Riluzole—Pruritus—Doxorubicin—breast cancer	9.68e-06	4.88e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.66e-06	0.000121	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2D6—breast cancer	9.58e-06	0.00012	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	9.56e-06	0.00012	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA2—breast cancer	9.54e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX2—breast cancer	9.54e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	9.47e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX4—breast cancer	9.42e-06	0.000118	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SULT1A1—breast cancer	9.42e-06	0.000118	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NCOA2—breast cancer	9.4e-06	0.000118	CbGpPWpGaD
Riluzole—Vomiting—Epirubicin—breast cancer	9.4e-06	4.74e-05	CcSEcCtD
Riluzole—Nausea—Methotrexate—breast cancer	9.38e-06	4.74e-05	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—breast cancer	9.36e-06	4.72e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—SLCO1B1—breast cancer	9.32e-06	0.000117	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A5—breast cancer	9.32e-06	0.000117	CbGpPWpGaD
Riluzole—Rash—Epirubicin—breast cancer	9.32e-06	4.7e-05	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—breast cancer	9.31e-06	4.7e-05	CcSEcCtD
Riluzole—Headache—Epirubicin—breast cancer	9.26e-06	4.67e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—IDH1—breast cancer	9.2e-06	0.000115	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA1—breast cancer	9.2e-06	0.000115	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—breast cancer	9.13e-06	0.000114	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—FASN—breast cancer	9.12e-06	0.000114	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	9.11e-06	0.000114	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NAT2—breast cancer	9.1e-06	0.000114	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BCHE—breast cancer	9.08e-06	0.000114	CbGpPWpGaD
Riluzole—Dizziness—Doxorubicin—breast cancer	9.05e-06	4.57e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—APRT—breast cancer	9e-06	0.000113	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC5A5—breast cancer	8.97e-06	0.000112	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	8.84e-06	0.000111	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	8.8e-06	0.00011	CbGpPWpGaD
Riluzole—Nausea—Epirubicin—breast cancer	8.78e-06	4.43e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—HRAS—breast cancer	8.76e-06	0.00011	CbGpPWpGaD
Riluzole—Vomiting—Doxorubicin—breast cancer	8.7e-06	4.39e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—NQO1—breast cancer	8.66e-06	0.000108	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC2A1—breast cancer	8.66e-06	0.000108	CbGpPWpGaD
Riluzole—Rash—Doxorubicin—breast cancer	8.62e-06	4.35e-05	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—breast cancer	8.62e-06	4.35e-05	CcSEcCtD
Riluzole—Headache—Doxorubicin—breast cancer	8.57e-06	4.32e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—ESRRA—breast cancer	8.47e-06	0.000106	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ANGPTL4—breast cancer	8.47e-06	0.000106	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP3A4—breast cancer	8.45e-06	0.000106	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—breast cancer	8.39e-06	0.000105	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1B1—breast cancer	8.3e-06	0.000104	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—breast cancer	8.26e-06	0.000103	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.23e-06	0.000103	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HSP90AA1—breast cancer	8.14e-06	0.000102	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—breast cancer	8.13e-06	4.1e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	8.05e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HADHB—breast cancer	8.02e-06	0.0001	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPI—breast cancer	8.02e-06	0.0001	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MED12—breast cancer	7.98e-06	9.99e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—DPYD—breast cancer	7.98e-06	9.99e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NCOA1—breast cancer	7.92e-06	9.92e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDOA—breast cancer	7.85e-06	9.83e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—STK11—breast cancer	7.81e-06	9.78e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP19A1—breast cancer	7.81e-06	9.78e-05	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—breast cancer	7.74e-06	9.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	7.68e-06	9.61e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDH1A1—breast cancer	7.66e-06	9.58e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDH7A1—breast cancer	7.66e-06	9.58e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOA3—breast cancer	7.63e-06	9.55e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A2—breast cancer	7.57e-06	9.48e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	7.57e-06	9.47e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.49e-06	9.38e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CPT1A—breast cancer	7.42e-06	9.29e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG2—breast cancer	7.42e-06	9.29e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTR—breast cancer	7.42e-06	9.29e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—UMPS—breast cancer	7.34e-06	9.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FHL2—breast cancer	7.34e-06	9.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADSL—breast cancer	7.34e-06	9.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PHGDH—breast cancer	7.34e-06	9.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NME1—breast cancer	7.34e-06	9.19e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HPGDS—breast cancer	7.27e-06	9.11e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COMT—breast cancer	7.26e-06	9.09e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HBA1—breast cancer	7.23e-06	9.05e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—breast cancer	7.22e-06	9.05e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BRIP1—breast cancer	7.2e-06	9.01e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LDHB—breast cancer	7.2e-06	9.01e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HPSE—breast cancer	7.2e-06	9.01e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—breast cancer	7.13e-06	8.92e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ITPR1—breast cancer	7.11e-06	8.9e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—breast cancer	7.06e-06	8.83e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ACHE—breast cancer	7.06e-06	8.83e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—breast cancer	6.84e-06	8.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMMR—breast cancer	6.82e-06	8.54e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCC1—breast cancer	6.82e-06	8.54e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA3—breast cancer	6.82e-06	8.54e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TYMS—breast cancer	6.72e-06	8.41e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP17A1—breast cancer	6.68e-06	8.36e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NCOR1—breast cancer	6.64e-06	8.31e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLA2G4A—breast cancer	6.64e-06	8.31e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—breast cancer	6.64e-06	8.31e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO1—breast cancer	6.61e-06	8.28e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS1—breast cancer	6.61e-06	8.28e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARGC1B—breast cancer	6.61e-06	8.27e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.59e-06	8.25e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.5e-06	8.14e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2D6—breast cancer	6.48e-06	8.12e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	6.43e-06	8.06e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	6.43e-06	8.06e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOA2—breast cancer	6.36e-06	7.97e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPX1—breast cancer	6.36e-06	7.96e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1A1—breast cancer	6.29e-06	7.88e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ERCC2—breast cancer	6.24e-06	7.81e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA4—breast cancer	6.24e-06	7.81e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA9—breast cancer	6.24e-06	7.81e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FASN—breast cancer	6.17e-06	7.73e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	6.16e-06	7.71e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCHE—breast cancer	6.15e-06	7.7e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	6.1e-06	7.64e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA2—breast cancer	6.08e-06	7.61e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX2—breast cancer	6.08e-06	7.61e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC5A5—breast cancer	6.07e-06	7.6e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX4—breast cancer	6.01e-06	7.52e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SULT1A1—breast cancer	6.01e-06	7.52e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA1—breast cancer	5.87e-06	7.35e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—IDH1—breast cancer	5.87e-06	7.35e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—breast cancer	5.87e-06	7.35e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A1—breast cancer	5.86e-06	7.34e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NQO1—breast cancer	5.86e-06	7.34e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NAT2—breast cancer	5.8e-06	7.26e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.74e-06	7.19e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP3A4—breast cancer	5.72e-06	7.16e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.69e-06	7.12e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP1B1—breast cancer	5.62e-06	7.04e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HSP90AA1—breast cancer	5.51e-06	6.9e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAV1—breast cancer	5.41e-06	6.78e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOA1—breast cancer	5.36e-06	6.71e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP19A1—breast cancer	5.29e-06	6.62e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—STK11—breast cancer	5.29e-06	6.62e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.25e-06	6.57e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MED12—breast cancer	5.09e-06	6.37e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—DPYD—breast cancer	5.09e-06	6.37e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDOA—breast cancer	5.01e-06	6.27e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.96e-06	6.21e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—breast cancer	4.93e-06	6.17e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—COMT—breast cancer	4.91e-06	6.15e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—breast cancer	4.89e-06	6.12e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOA3—breast cancer	4.86e-06	6.09e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A2—breast cancer	4.83e-06	6.04e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—breast cancer	4.82e-06	6.04e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ITPR1—breast cancer	4.81e-06	6.02e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.78e-06	5.98e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTR—breast cancer	4.73e-06	5.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CPT1A—breast cancer	4.73e-06	5.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG2—breast cancer	4.73e-06	5.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HPGDS—breast cancer	4.64e-06	5.81e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—breast cancer	4.63e-06	5.8e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HBA1—breast cancer	4.61e-06	5.77e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TYMS—breast cancer	4.55e-06	5.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ACHE—breast cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—breast cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—breast cancer	4.49e-06	5.63e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLA2G4A—breast cancer	4.49e-06	5.63e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOR1—breast cancer	4.49e-06	5.63e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CD—breast cancer	4.33e-06	5.43e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX1—breast cancer	4.3e-06	5.39e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—breast cancer	4.28e-06	5.36e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP17A1—breast cancer	4.26e-06	5.33e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ERCC2—breast cancer	4.23e-06	5.29e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO1—breast cancer	4.22e-06	5.28e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS1—breast cancer	4.22e-06	5.28e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.2e-06	5.26e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.15e-06	5.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2D6—breast cancer	4.13e-06	5.18e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NOS3—breast cancer	4.09e-06	5.12e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOA2—breast cancer	4.06e-06	5.08e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—breast cancer	3.97e-06	4.97e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FASN—breast cancer	3.94e-06	4.93e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCHE—breast cancer	3.92e-06	4.91e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC5A5—breast cancer	3.87e-06	4.85e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CB—breast cancer	3.78e-06	4.73e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—breast cancer	3.74e-06	4.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A1—breast cancer	3.74e-06	4.68e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NQO1—breast cancer	3.74e-06	4.68e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAV1—breast cancer	3.66e-06	4.59e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.66e-06	4.58e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP3A4—breast cancer	3.65e-06	4.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.63e-06	4.54e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1B1—breast cancer	3.58e-06	4.49e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.52e-06	4.4e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.5e-06	4.38e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOA1—breast cancer	3.42e-06	4.28e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—STK11—breast cancer	3.37e-06	4.22e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP19A1—breast cancer	3.37e-06	4.22e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—breast cancer	3.34e-06	4.18e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTEN—breast cancer	3.26e-06	4.09e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.16e-06	3.96e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COMT—breast cancer	3.13e-06	3.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—breast cancer	3.12e-06	3.9e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—breast cancer	3.08e-06	3.85e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ITPR1—breast cancer	3.07e-06	3.84e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—breast cancer	2.95e-06	3.7e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CD—breast cancer	2.93e-06	3.67e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TYMS—breast cancer	2.9e-06	3.63e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—breast cancer	2.9e-06	3.63e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOR1—breast cancer	2.87e-06	3.59e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.87e-06	3.59e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—breast cancer	2.87e-06	3.59e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NOS3—breast cancer	2.77e-06	3.47e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX1—breast cancer	2.74e-06	3.44e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1A1—breast cancer	2.72e-06	3.4e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ERCC2—breast cancer	2.69e-06	3.37e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CB—breast cancer	2.56e-06	3.2e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—breast cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—breast cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAV1—breast cancer	2.34e-06	2.92e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—breast cancer	2.3e-06	2.88e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.23e-06	2.79e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTEN—breast cancer	2.21e-06	2.77e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—breast cancer	2.13e-06	2.66e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—breast cancer	1.88e-06	2.36e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.87e-06	2.34e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—breast cancer	1.85e-06	2.31e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NOS3—breast cancer	1.77e-06	2.21e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.63e-06	2.04e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—breast cancer	1.62e-06	2.02e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—breast cancer	1.56e-06	1.95e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTEN—breast cancer	1.41e-06	1.76e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—breast cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—breast cancer	9.94e-07	1.24e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—breast cancer	8.12e-07	1.02e-05	CbGpPWpGaD
